Background: Ketorolac is known to be effective in releasing uterine cramping pain common in post cesarean section patients. This study was designed to compare the analgesic effects and adverse effects of ketorolac plus low dose opioids as opposed to opioids alone in patients receiving intravenous patient-controlled analgesia after cesarean section. Methods: Patients who received postoperative intravenous patient-controlled analgesia were randomly assigned to two groups: (A) ketorolac 1.03 mg/ml) +fentanyl (4.31 μg/ml) +morphine (0.172 mg/ml), (B) fentanyl (15 μg/ml) +morphine (0.5 mg/ml). During the postoperative 72-hour period pain intensity was evaluated with verbal rating scale (VRS) on a scale of 0-4 (from ”none” to ”excruciating”), and side effects were recorded. Results: No statistical difference (P>0.05) was found in VRS scores. Significantly higher side effects were found in Group B (drowsy, dizziness, nausea, vomiting). Conclusions: The ketorolac group (Group A) received the same postoperative analgesic effect, on lower dosage opiates and with lower side effects than the opiate group (Group B). We suggest use of ketorolac to replace some opioids for postoperative analgesia when no contraindications for NSAID5 use are present.
Background: Ketorolac is known to be effective in releasing uterine cramping pain common in post cesarean section patients. This study was designed to compare the analgesic effects and adverse effects of ketorolac plus low dose opioids as opposed to opioids alone in patients receiving intravenous patient-controlled analgesia after cesarean section. Methods: Patients who received postoperative intravenous patient-controlled analgesia were randomly assigned to two groups: (A) ketorolac 1.03 mg/ml) +fentanyl (4.31 μg/ml) +morphine (0.172 mg/ml), (B) fentanyl (15 μg/ml) +morphine (0.5 mg/ml). During the postoperative 72-hour period pain intensity was evaluated with verbal rating scale (VRS) on a scale of 0-4 (from ”none” to ”excruciating”), and side effects were recorded. Results: No statistical difference (P>0.05) was found in VRS scores. Significantly higher side effects were found in Group B (drowsy, dizziness, nausea, vomiting). Conclusions: The ketorolac group (Group A) received the same postoperative analgesic effect, on lower dosage opiates and with lower side effects than the opiate group (Group B). We suggest use of ketorolac to replace some opioids for postoperative analgesia when no contraindications for NSAID5 use are present.